Several surgical procedures, such as biliointestinal bypass or gastric banding, and pharmacological interventions, such as pancreatic lipase inhibitors or Glucagon-Like Peptide 1 agonists, are applied for the management of obesity. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.